EyePoint (EYPT) Exchange Rate Effect (2010 - 2019)
EyePoint (EYPT) posted Exchange Rate Effect of $1000.0 for Q4 2019, up 200.0% sequentially from -$1000.0 in Q4 2018, and up 200.0% YoY from $333.33 in Q4 2018.
Powered by 
Analysis
EyePoint (EYPT) Exchange Rate Effect (2010 - 2019) Analysis & Trends
EyePoint has reported Exchange Rate Effect for 10 years, with the latest figure at $1000.0 in Q4 2019.
- Quarterly Exchange Rate Effect rose 200.0% year-over-year to $1000.0 in Q4 2019, while the trailing twelve-month figure through Jun 2020 was $1000.0 (up 133.33% YoY) and the FY2019 annual result came in at $1000.0, changed N/A from the prior year.
- Exchange Rate Effect rose to $1000.0 in Q4 2019 per EYPT's latest filing, from -$1000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $6000.0 in Q2 2017 and troughed at -$8000.0 in Q2 2016.
- A 5-year average of -$1312.5 and a median of -$2000.0 in 2016 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2015 and 2016: Exchange Rate Effect jumped 600.0% in 2015, then plunged 260.0% in 2016.
- Over 5 years, Exchange Rate Effect stood at -$5000.0 in 2015, then soared by 60.0% to -$2000.0 in 2016, then soared by 400.0% to $6000.0 in 2017, then slumped by 116.67% to -$1000.0 in 2018, then surged by 200.0% to $1000.0 in 2019.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $1000.0, -$1000.0, and -$2000.0 for Q4 2019, Q4 2018, and Q3 2018 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | EyePoint | 398.53 Mn | 218.06 Mn | 507,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | 1,000.00 |
| Dec 31, 2018 | -1,000.00 |
| Sep 30, 2018 | -2,000.00 |
| Jun 30, 2018 | -2,000.00 |
| Dec 31, 2017 | 6,000.00 |
| Sep 30, 2017 | 4,000.00 |
| Jun 30, 2017 | 6,000.00 |
| Mar 31, 2017 | -1,000.00 |
| Dec 31, 2016 | -2,000.00 |
| Sep 30, 2016 | -8,000.00 |
| Jun 30, 2016 | -8,000.00 |
| Mar 31, 2016 | -4,000.00 |
| Dec 31, 2015 | -5,000.00 |
| Sep 30, 2015 | -3,000.00 |
| Jun 30, 2015 | 5,000.00 |
| Mar 31, 2015 | -7,000.00 |
| Dec 31, 2014 | -5,000.00 |
| Sep 30, 2014 | -5,000.00 |
| Jun 30, 2014 | -1,000.00 |
| Mar 31, 2014 | -5,000.00 |